FGD5 and neoplasm: Further experiments revealed that FGD5-AS1 can facilitate the expression of PD-L1 through miR-454-3p/ZEB1 signaling axis or miR-142-5p to promote tumor progression and cisplatin resistance [21,96], and the above mechanisms have also been verified in OC cells [56].